Jeffrey M Sobell

Guest Editor for the following articles:

Mar
2005
Vol. 24. No. 1

Biologic Agents for Psoriasis, Introduction

Jeffrey M Sobell, MD

The aim of this issue is to take this discussion one step further and examine the incorporation of these agents successfully into clinical practice.

MORE
Sep
2013
Vol. 32. No. 3

Hand Dermatitis: Review of Clinical Features and Treatment Options

Spring Golden, MD | Tatyana Shaw, MD

Hand dermatitis affects a significant portion of the population and can be caused by a variety of endogenous factors (ie, atopy) as well as occupational and environmental exposures. It is often a chronic problem with high costs to individuals, employers, and society. This review discusses subtypes of hand dermatitis based on their clinical features and pathogenesis. It also offers an approach to treatment.
Semin Cutan Med Surg 32:147-157 © 2013 Frontline Medical Communications

MORE
Jun
2014
Vol. 33. No. 4

Introduction

Craig L. Leonardi, MD

Dermatology has evolved into one of the most dynamic specialties in medicine. Advances in cellular and molecular biology have translated into clinical progress in the management of multiple conditions that dermatologists treat

MORE
Sep
2013
Vol. 32. No. 3

Noninfectious Granulomatous Dermatitides: A Review of 8 Disorders (Part 1 of 3)

Alice B. Gottlieb, PhD | Ari M. Goldminz, MD

In this review we focus on 2 of the noninfectious granulomatous dermatitides, granuloma annulare and interstitial granulomatous dermatitis (the remaining 6 will be discussed in Parts 2 and 3), with an overview of their clinical and histological presentations, differential diagnoses, and treatment options. The disorders we discuss are polymorphic in their clinical and histopathological presentations, follow chronic or undulating disease courses, and are typically recalcitrant to therapeutic interventions. Although the clinical history may be helpful, careful and thorough histopathological examination is required. Established treatment algorithms for these disorders are lacking, and no randomized, placebo-controlled studies have been published. Future investigations should focus on the evaluation of larger cohorts, not only to establish treatment recommendations in randomized, placebocontrolled trials, but also to reach a greater understanding of disease pathogenesis and clinical-pathological presentation.
Semin Cutan Med Surg 32:177-182 © 2013 Frontline Medical Communications

MORE